Detalles de la búsqueda
1.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Gynecol Oncol
; 184: 224-235, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340648
2.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123694
3.
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
Gynecol Oncol
; 171: 151-158, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905875
4.
Assessment of Attitudes Toward Initiation of Immediate Adjuvant Chemotherapy for Colon Cancer.
J Surg Res
; 283: 658-665, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455419
5.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903380
6.
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Gynecol Oncol
; 163(2): 392-397, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548162
7.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Gynecol Oncol
; 160(1): 244-251, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109392
8.
Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population.
Int J Behav Med
; 28(1): 140-150, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598780
9.
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.
Gynecol Oncol
; 156(2): 467-474, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837831
10.
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Gynecol Oncol
; 156(1): 131-139, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31759774
11.
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
Int J Gynecol Cancer
; 30(5): 596-601, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32114513
12.
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).
Gynecol Oncol
; 155(3): 452-460, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679787
13.
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol
; 154(1): 183-188, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104905
14.
Perceptions of changes in clinical, informational, and supportive relationships after end of treatment among parents of young childhood cancer survivors.
Psychooncology
; 28(4): 913-919, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30812064
15.
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Support Care Cancer
; 27(2): 531-538, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003341
16.
Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial.
Support Care Cancer
; 27(9): 3301-3310, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30612237
17.
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Lancet Oncol
; 19(8): 1126-1134, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026002
18.
Validation of PROMIS emotional distress short form scales for cervical cancer.
Gynecol Oncol
; 151(1): 111-116, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30078504
19.
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 150(1): 119-126, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29778506
20.
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(1): 122-129, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28190649